Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2023-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
关于调整2019年限制性股票激励计划回购价格的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the adjustment of the repurchase price of a 2019 restricted stock incentive plan. It details board and supervisory meetings, approvals, legal opinions, and procedural compliance related to the stock incentive plan and its repurchase price adjustment. The document is a formal announcement of a corporate action related to stock incentives and repurchase price adjustments, not a full financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive information about the adjustment and approvals. The content fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about corporate governance and stock incentive plan adjustments that do not fit other more specific categories.
2023-04-26 Chinese
关于修订《公司章程》的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the revision of the company's Articles of Association (公司章程). It details changes approved by the board related to share repurchase and stock incentive plans, and the addition of a clause about board authorization for stock issuance. It also mentions that the amendments will be submitted to the 2022 annual general meeting for approval. The document is a formal announcement of corporate governance changes and procedural updates, not a full report or financial statement. It does not contain financial data or detailed management discussion, nor is it a call transcript or legal proceeding update. The content fits best under Board/Management Information (MANG) as it relates to board decisions and governance changes. The document length is short (2657 characters), and it is not merely announcing a report publication but providing substantive governance information.
2023-04-26 Chinese
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 12th meeting of the 3rd Board of Directors of the company, including approvals of the 2022 annual general manager work report, 2022 annual board work report, 2022 annual report and its summary, 2022 audit report, 2022 financial statements, internal control reports, profit distribution plan, and other related matters. It also mentions that these reports and documents are disclosed on the official information disclosure website (cninfo.com.cn) and newspapers, and that these matters will be submitted to the 2022 annual shareholders meeting for approval. The document is not the reports themselves but a board meeting resolution announcement regarding these reports and proposals. It includes voting results and references to other announcements for detailed reports. The document length is 6573 characters, which is relatively short for full reports but appropriate for a board meeting resolution announcement. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of board resolutions and related disclosures, not the full annual report or audit report itself.
2023-04-26 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding changes in accounting policies by the company 西藏易明西雅医药科技股份有限公司. It references specific accounting standards and interpretations issued by the Ministry of Finance of the People's Republic of China, detailing the reasons, content, and impact of the accounting policy changes. The document explicitly states that these changes do not require board or shareholder approval and do not materially affect financial statements. The document length is 2865 characters, which is relatively short and primarily serves as a disclosure announcement rather than a full financial report. It does not contain actual financial statements or detailed financial data but rather explains the policy changes and their implications. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-26 Chinese
2022年年度审计报告
Regulatory Filings
2023-04-26 Chinese
关于回购注销2019年限制性股票激励计划部分限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the repurchase and cancellation of restricted shares under a 2019 restricted stock incentive plan. It details the number of shares to be repurchased, the price, the approval process, and the impact on the company's share capital. It includes references to board and supervisory meetings, independent director opinions, and legal opinions. The document is a formal announcement of a share repurchase and cancellation event, not a full financial report or audit. It does not contain financial statements or earnings data but focuses on a capital change event related to share repurchase and cancellation. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and content support this classification with high confidence.
2023-04-26 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.